Glucagon-induced extracellular cAMP regulates hepatic lipid metabolism

The Journal of Endocrinology
Sihan LvBing Luan

Abstract

Hormonal signals help to maintain glucose and lipid homeostasis in the liver during the periods of fasting. Glucagon, a pancreas-derived hormone induced by fasting, promotes gluconeogenesis through induction of intracellular cAMP production. Glucagon also stimulates hepatic fatty acid oxidation but the underlying mechanism is poorly characterized. Here we report that following the acute induction of gluconeogenic genes Glucose 6 phosphatase (G6Pase) and Phosphoenolpyruvate carboxykinase (Pepck) expression through cAMP-response element-binding protein (CREB), glucagon triggers a second delayed phase of fatty acid oxidation genes Acyl-coenzyme A oxidase (Aox) and Carnitine palmitoyltransferase 1a (Cpt1a) expression via extracellular cAMP. Increase in extracellular cAMP promotes PPARα activity through direct phosphorylation by AMP-activated protein kinase (AMPK), while inhibition of cAMP efflux greatly attenuates Aox and Cpt1a expression. Importantly, cAMP injection improves lipid homeostasis in fasted mice and obese mice, while inhibition of cAMP efflux deteriorates hepatic steatosis in fasted mice. Collectively, our results demonstrate the vital role of glucagon-stimulated extracellular cAMP in the regulation of hepatic lipid me...Continue Reading

References

Jan 1, 1991·Annual Review of Pharmacology and Toxicology·E K Jackson
Dec 30, 1971·Annals of the New York Academy of Sciences·J H ExtonC R Park
Sep 16, 2000·Hypertension·R K DubeyE K Jackson
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giulio MarchesiniMario Rizzetto
Jul 29, 2003·Journal of Nutritional Science and Vitaminology·Koutarou MuroyamaMasamitsu Miyoshi
Sep 29, 2004·Diabetes Care·Earl S FordAli H Mokdad
Jun 25, 2005·Obesity Research·Marci B StrouchGale B Carey
Mar 30, 2006·Journal of Cell Science·Ivette AymerichMarçal Pastor-Anglada
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jonathan M MaherCurtis D Klaassen
Apr 29, 2008·Molecular Cell·Dana M GwinnReuben J Shaw
May 14, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew D MerrellNathan J Cherrington
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Dec 3, 2008·Cell Metabolism·Christine LonguetDaniel J Drucker
Feb 18, 2009·The Journal of Clinical Investigation·Zhongsheng PengBruce N Cronstein
Jan 20, 2011·Journal of Lipid Research·Amanda J HooperJohn R Burnett
Feb 25, 2011·Nature Reviews. Molecular Cell Biology·Judith Y Altarejos, Marc Montminy
May 14, 2011·Cell·Biao WangMarc Montminy
Nov 9, 2011·Alimentary Pharmacology & Therapeutics·A BirerdincZ M Younossi
Nov 29, 2011·Journal of Hepatology·Beicheng Sun, Michael Karin
Jan 5, 2012·The Journal of Clinical Investigation·Roger H Unger, Alan D Cherrington
Apr 13, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lauren M Aleksunes, Curtis D Klaassen
Feb 19, 2013·Cell Metabolism·Ferdinand von MeyennMarkus Stoffel
Jun 8, 2013·Nature Medicine·Dale S Edgerton, Alan D Cherrington
Feb 26, 2014·Journal of Applied Genetics·Jalusa Deon KichShawn Michelle Dunkin Bearson
Sep 10, 2014·Journal of Clinical Pharmacology·Marloes G J van DongenJacobus Burggraaf
May 12, 2015·PloS One·Rita S PatarrãoM Paula Macedo
Aug 15, 2015·Bioorganic & Medicinal Chemistry Letters·Matthew F Sammons, Esther C Y Lee
Mar 18, 2016·Scientific Reports·Zhen-Ning ZhangBing Luan
Jun 24, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nicolás Eric PonceMaria Pilar Aoki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.